First Trust Advisors LP Sells 46,390 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

First Trust Advisors LP trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 45.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 56,116 shares of the company's stock after selling 46,390 shares during the quarter. First Trust Advisors LP's holdings in Option Care Health were worth $1,302,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new position in Option Care Health during the 4th quarter worth approximately $26,000. UMB Bank n.a. raised its stake in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the period. Signaturefd LLC raised its stake in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after buying an additional 1,005 shares during the period. Quadrant Capital Group LLC raised its stake in Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares during the period. Finally, Sterling Capital Management LLC raised its stake in Option Care Health by 638.5% during the 4th quarter. Sterling Capital Management LLC now owns 2,954 shares of the company's stock worth $69,000 after buying an additional 2,554 shares during the period. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by corporate insiders.

Option Care Health Stock Performance

Shares of OPCH traded down $0.18 on Monday, reaching $31.67. 349,776 shares of the company's stock traded hands, compared to its average volume of 1,837,993. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market cap of $5.19 billion, a PE ratio of 26.66, a PEG ratio of 2.30 and a beta of 0.76. The stock's 50 day simple moving average is $33.24 and its two-hundred day simple moving average is $28.89. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period in the prior year, the company earned $0.26 earnings per share. Option Care Health's revenue was up 16.3% compared to the same quarter last year. On average, analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently weighed in on OPCH shares. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. JPMorgan Chase & Co. increased their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, JMP Securities reissued a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Option Care Health has a consensus rating of "Moderate Buy" and a consensus target price of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.